- AU$43.82m
- AU$50.50m
- $22.82m
- 30
- 56
- 67
- 50
Annual income statement for Next Science, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.44 | 8.95 | 11.7 | 22.2 | 22.8 |
| Cost of Revenue | |||||
| Gross Profit | 2.92 | 6.94 | 9.15 | 16.2 | 18.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 15.6 | 18.4 | 24.4 | 37.7 | 33.1 |
| Operating Profit | -12.2 | -9.48 | -12.7 | -15.6 | -10.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -11.9 | -9.35 | -12.7 | -16.3 | -10.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -11.9 | -9.35 | -12.7 | -16.3 | -10.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -11.9 | -9.35 | -12.7 | -16.3 | -10.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -11.9 | -9.35 | -12.7 | -16.3 | -10.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.065 | -0.048 | -0.06 | -0.071 | -0.036 |